Samsung Biologics Recognized for Advancing Sustainability at 2026 CDMO Leadership Awards
- Written by PR Newswire
![]() |
- Reinforcing long-term commitment to embedding sustainability across operations and partnerships
- Continuing to support clients in delivering high-quality, life-saving medicines to patients worldwide
INCHEON, South Korea, March 26, 2026 /PRNewswire/ -- Samsung Biologics (KRX: 207940.KS), a leading contract development and manufacturing organization...
Read more: Samsung Biologics Recognized for Advancing Sustainability at 2026 CDMO Leadership Awards















